WebApr 4, 2016 · Dr. Therese Bittermann, MD, is a Hematology specialist in Philadelphia, Pennsylvania. She attended and graduated from medical school in 2010, having over 13 … WebMar 18, 2024 · Therese Bittermann is supported by a National Institute of Diabetes and Digestive and Kidney Diseases Grant K08-DK117013. Douglas E. Schaubel is supported by a National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK070869.
Therese (Tess) Bittermann, MD, MSCE CCEB - University of …
WebJul 10, 2024 · Therese Bittermann, Division of Gastroenterology & Hepatology, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street – 2 Dulles, Philadelphia, PA 19130, USA. Email: [email protected]. Search for more papers by this author [email protected] Risk factors for hepatocellular carcinoma (HCC) recur-rence after liver transplantation have been well described. It has been surmised that longer time on the waitlist may select for tumors with a lower-risk of recurrence posttransplant, as patients with unfavor- crystal naming convention
Recipient and Center Factors Associated With... : Transplantation
WebJun 21, 2024 · Address reprint requests to Therese Bittermann, M.D., M.S.C.E., Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of … WebSep 28, 2024 · Primary biliary cholangitis (PBC) is a rare autoimmune liver disease with limited therapeutic options that can lead to end-stage liver disease and death. Until recently, ursodeoxycholic acid (UDCA) was the sole approved treatment for PBC. Yet, 20%–30% of patients have an incomplete biochemical response to UDCA, as measured by alkaline … WebMar 24, 2024 · Bittermann, Therese MD, MSCE 1,2; Mahmud, Nadim MD 1,2; Weinberg, Ethan M. MD 1; Reddy, K. Rajender MD 1 Author Information 1 Division of … crystal nancy toner